149
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats

, , , &
Pages 873-887 | Received 29 Aug 2010, Accepted 10 Mar 2011, Published online: 26 Apr 2011

References

  • Tator CH. Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery. 2006;59:957–82.
  • Rossignol S, Schwab M, Schwartz M, Fehlings MG. Spinal cord injury: time to move? J Neurosci. 2007;27:11782–92.
  • Adams M, Carlstedt T, Cavanagh J, Lemon RN, McKernan R, Priestley JV, . International spinal research trust research strategy. III. A discussion document. Spinal Cord. 2007;45:2–14.
  • Fitch MT, Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol. 2008;209:294–301.
  • Lu P, Tuszynski MH. Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol. 2008;209:313–20.
  • Bradbury EJ, McMahon SB. Spinal cord repair strategies: why do they work? Nat Rev Neurosci. 2006;7:644–53.
  • Oudega M, Xu XM. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma. 2006;23:453–67.
  • Pearse DD, Bunge MB. Designing cell- and gene-based regeneration strategies to repair the injured spinal cord. J Neurotrauma. 2006;23:438–52.
  • Raisman G, Carlstedt T, Choi D, Li Y. Clinical prospects for transplantation of OECs in the repair of brachial and lumbo-sacral plexus injuries: opening a door. Exp Neurol. May 19. [epub ahead of print], doi:10.1016/j.expneurol.2010.05.007.
  • Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol. 2008;209:353–67.
  • Franssen EH, de Bree FM, Verhaagen J. Olfactory ensheathing glia: their contribution to primary olfactory nervous system regeneration and their regenerative potential following transplantation into the injured spinal cord. Brain Res Rev. 2007;56:236–58.
  • Munoz-Quiles C, Santos-Benito FF, Llamusi MB, Ramon-Cueto A. Chronic spinal injury repair by olfactory bulb ensheathing glia and feasibility for autologous therapy. J Neuropathol Exp Neurol. 2009;68:1294–308.
  • Coutts M, Keirstead HS. Stem cells for the treatment of spinal cord injury. Exp Neurol. 2008;209:368–77.
  • Lowry N, Goderie SK, Adamo M, Lederman P, Charniga C, Gill J, . Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury. Exp Neurol. 2008;209:510–22.
  • Parr AM, Kulbatski I, Wang XH, Keating A, Tator CH. Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery. Surg Neurol. 2008;70:600–7.
  • Sharp J, Keirstead HS. Stem cell-based cell replacement strategies for the central nervous system. Neurosci Lett. 2009; 456:107–11.
  • Kamada T, Koda M, Dezawa M, Anahara R, Toyama Y, Yoshinaga K, . Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord. Neuropathology. 2011;31:48–58.
  • Singec I, Jandial R, Crain A, Nikkhah G, Snyder EY. The leading edge of stem cell therapeutics. Annu Rev Med. 2007;58:313–28.
  • Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364–70.
  • Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418: 41–9.
  • Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci. 2001;14:1771–6.
  • Caddick J, Kingham PJ, Gardiner NJ, Wiberg M, Terenghi G. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage. Glia. 2006;54:840–9.
  • Brohlin M, Mahay D, Novikov LN, Terenghi G, Wiberg M, Shawcross SG, . Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res. 2009;64:41–9.
  • Kocsis JD, Akiyama Y, Radtke C. Neural precursors as a cell source to repair the demyelinated spinal cord. J Neurotrauma. 2004;21:441–9.
  • Enzmann GU, Benton RL, Talbott JF, Cao QL, Whittemore SR. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma. 2006;23: 479–95.
  • Dezawa M. Systematic neuronal and muscle induction systems in bone marrow stromal cells: the potential for tissue reconstruction in neurodegenerative and muscle degenerative diseases. Med Mol Morphol. 2008;41:14–9.
  • Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats: similarities to astrocyte grafts. Proc Natl Acad Sci USA. 1998;95: 3908–13.
  • Novikov LN, Novikova LN, Mosahebi A, Wiberg M, Terenghi G, Kellerth JO. A novel biodegradable implant for neuronal rescue and regeneration after spinal cord injury. Biomaterials. 2002;23:3369–76.
  • Novikova LN, Novikov LN, Kellerth JO. Differential effects of neurotrophins on neuronal survival and axonal regeneration after spinal cord injury in adult rats. J Comp Neurol. 2002;452:255–63.
  • Paxinos G. The rat Nervous System, Sydney: Academic Press; 1985. 362.
  • Novikov LN. Labeling of central projections of primary afferents in adult rats: a comparison between biotinylated dextran amine, neurobiotin and Phaseolus vulgaris-leucoagglutinin. J Neurosci Methods. 2001;112:145–54.
  • Novikova LN, Novikov LN, Kellerth JO. Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci. 2000;12:776–80.
  • Ma JJ, Novikov LN, Wiberg M, Kellerth JO. Delayed loss of spinal motoneurons after peripheral nerve injury in adult rats: a quantitative morphological study. Exp Brain Res. 2001; 139:216–23.
  • Novikov L, Novikova L, Kellerth J-O. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience. 1997;79:765–74.
  • Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, . Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA. 2002;99:2199–204.
  • Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, . Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA. 2010;107:8639–43.
  • Ratajczak MZ, Shin DM, Kucia M. Very small embryonic/epiblast-like stem cells: a missing link to support the germ line hypothesis of cancer development? Am J Pathol. 2009; 174:1985–92.
  • Neuhuber B, Gallo G, Howard L, Kostura L, Mackay A, Fischer I. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res. 2004;77: 192–204.
  • Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res. 2004;77:174–91.
  • Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science. 2002;297:1299.
  • Swanger SA, Neuhuber B, Himes BT, Bakshi A, Fischer I. |Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant. 2005;14: 775–86.
  • Yoshihara H, Shumsky JS, Neuhuber B, Otsuka T, Fischer I, Murray M. Combining motor training with transplantation of rat bone marrow stromal cells does not improve repair or recovery in rats with thoracic contusion injuries. Brain Res. 2006;1119:65–75.
  • Someya Y, Koda M, Dezawa M, Kadota T, Hashimoto M, Kamada T, . Reduction of cystic cavity, promotion of axonal regeneration and sparing, and functional recovery with transplanted bone marrow stromal cell-derived Schwann cells after contusion injury to the adult rat spinal cord. J Neurosurg Spine. 2008;9:600–10.
  • Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, . Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 2010;1343:226–35.
  • Park HW, Lim MJ, Jung H, Lee SP, Paik KS, Chang MS. Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia. 2010; 58:1118–32.
  • Hejcl A, Sedy J, Kapcalova M, Arboleda TD, Amemori T, Likavcanova-Masinova K, . HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells Dev. 2010;19:1535–46.
  • Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K, . BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci. 2009;29:14932–41.
  • Abrams MB, Dominguez C, Pernold K, Reger R, Wiesenfeld-Hallin Z, Olson L, . Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor Neurol Neurosci. 2009;27:307–21.
  • Zurita M, Vaquero J, Bonilla C, Santos M, De Haro J, Oya S, . Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation. 2008;86:845–53.
  • Brass LM. Bone marrow for the brain? Exp Neurol. 2006; 199:16–19.
  • English D, Klasko SK, Sanberg PR. Elusive mechanisms of ‘stem cell’-mediated repair of cerebral damage. Exp Neurol. 2006;199:10–15.
  • Li Y, Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett. 2009;456:120–3.
  • Chopp M, Mahmood A, Lu DY, Li Y. Mesenchymal stem cell treatment of traumatic brain injury. J Neurosurg. 2009; 110:1186–7.
  • Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, . Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002;59: 514–23.
  • Nandoe RD, Hurtado A, Levi AD, Grotenhuis A, Oudega M. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant. 2006;15: 563–77.
  • Garcia R, Aguiar J, Alberti E, de la Cuétara K, Pavon N. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun. 2004;316:753–4.
  • Neuhuber B, Timothy HB, Shumsky JS, Gallo G, Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res. 2005;1035:73–85.
  • Schuhmann B, Dietrich A, Sel S, Hahn C, Klingenspor M, Lommatzsch M, . A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol. 2005;163: 15–23.
  • Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2006;198: 54–64.
  • Yaghoobi MM, Mowla SJ. Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neurosci Lett. 2006;397:149–54.
  • Chen CJ, Ou YC, Liao SL, Chen WY, Chen SY, Wu CW, . Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol. 2007;204:443–53.
  • Hokari M, Kuroda S, Shichinohe H, Yano S, Hida K, Iwasaki Y. Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. J Neurosci Res. 2008;86:1024–35.
  • Karussis D, Kassis I, Kurkalli BG, Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci. 2008;265:131–5.
  • Zhukareva V, Obrocka M, Houle JD, Fischer I, Neuhuber B. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine. 2010;50:317–21.
  • Shen LH, Li Y, Chopp M. Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats. Glia. 2010;58: 1074–81.
  • Novikova L, Novikov L, Kellerth J-O. Brain-derived neurotrophic factor reduces necrotic zone and supports neuronal survival after spinal cord hemisection in adult rats. Neurosci Lett. 1996;220:203–6.
  • Namiki J, Kojima A, Tator CH. Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma. 2000;17:1219–30.
  • Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ, Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Tα1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci. 1997;17:9583–95.
  • Houle JD, Ye JH. Survival of chronically-injured neurons can be prolonged by treatment with neurotrophic factors. Neuroscience. 1999;94:929–36.
  • Ruitenberg MJ, Plant GW, Hamers FP, Wortel J, Blits B, Dijkhuizen PA, . Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J Neurosci. 2003;23:7045–58.
  • Tobias CA, Shumsky JS, Shibata M, Tuszynski MH, Fischer I, Tessler A, . Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotornized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp Neurol. 2003;184:97–113.
  • Liu Y, Himes BT, Murray M, Tessler A, Fischer I. Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp Neurol. 2002;178: 150–64.
  • Deumens R, Koopmans GC, Joosten EAJ. Regeneration of descending axon tracts after spinal cord injury. Prog Neurobiol. 2005;77:57–89.
  • Widenfalk J, Lipson A, Jubran M, Hofstetter C, Ebendal T, Cao Y, . Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience. 2003;120: 951–60.
  • Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, . Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692–9.
  • Wu S, Suzuki Y, Ejiri Y, Noda T, Bai H, Kitada M, . Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res. 2003;72:343–51.
  • Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol. 2004;190:17–31.
  • Himes BT, Neuhuber B, Coleman C, Kushner R, Swanger SA, Kopen GC, . Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair. 2006;20:278–96.
  • Ide C, Nakai Y, Nakano N, Seo TB, Yamada Y, Endo K, . Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat. Brain Res. 2010;1332:32–47.
  • Wright KT, El Masri W, Osman A, Roberts S, Chamberlain G, Ashton BA, . Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A. Biochem Biophys Res Commun. 2007;354:559–66.
  • Raisman G. Myelin inhibitors: does NO mean GO? Nat Rev Neurosci. 2004;5:157–61.
  • Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, . Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci. 2005;8:346–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.